Astera Labs, Inc. Financial Summary

Quick Answer

Astera Labs, Inc. reported Total Revenue of $852.52 million for fiscal year 2025.

Astera Labs, Inc. — Key Financials by Year

Metric 2025 2024 2023 2022 2021
Total Revenue $852.52M
+115.1%
$396.29M
+242.2%
$115.79M
+45.0%
$79.87M
Revenue (ASC 606) $852.52M
+115.1%
$396.29M
+242.2%
$115.79M
+45.0%
$79.87M
Net Income $219.13M
+362.7%
-$83.42M
-217.7%
-$26.26M
+55.0%
-$58.34M
Diluted EPS $1.22
+290.6%
-$0.64
+9.9%
-$0.71
+58.5%
-$1.71
Total Assets $1.53B
+45.3%
$1.05B
+437.2%
$196.29M
Cash and Equivalents $167.61M
+110.7%
$79.55M
+76.4%
$45.10M
Stockholders Equity $1.36B
+41.3%
$964.80M
+1087.5%
-$97.70M
-14.5%
-$85.29M
-114.5%
-$39.76M
R&D Expense $304.00M
+51.4%
$200.83M
+173.6%
$73.41M
-0.4%
$73.71M
Operating Income $173.42M
+249.4%
-$116.07M
-293.5%
-$29.50M
+51.0%
-$60.19M
Gross Profit $645.26M
+113.2%
$302.70M
+279.2%
$79.83M
+36.0%
$58.68M
Shares Outstanding 170.19M
+5.0%
162.02M
+285.3%
42.05M

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue September 30, 2025 $230.57M +103.9% +20.1%
Revenue (ASC 606) September 30, 2025 $230.57M +103.9% +20.1%
Net Income September 30, 2025 $91.11M +1300.0% +77.9%
Diluted EPS September 30, 2025 $0.50 +1100.0% +72.4%
Total Assets September 30, 2025 $1.40B +42.5% +10.2%
Cash and Equivalents September 30, 2025 $140.41M +11.3% -13.5%
Stockholders Equity September 30, 2025 $1.27B +43.0% +12.0%
R&D Expense September 30, 2025 $78.93M +55.8% +18.3%
Operating Income September 30, 2025 $55.41M +722.8% +39.3%
Gross Profit September 30, 2025 $175.81M +100.1% +20.8%
Shares Outstanding September 30, 2025 168.90M +6.5% +1.6%
  • Astera Labs, Inc. reported Total Revenue of $852.52 million for fiscal year 2025.
  • Astera Labs, Inc. showed an increase of +115.1% in Total Revenue compared to the prior fiscal year.
  • Astera Labs, Inc. reported Revenue (ASC 606) of $852.52 million for fiscal year 2025.
  • Astera Labs, Inc. showed an increase of +115.1% in Revenue (ASC 606) compared to the prior fiscal year.
  • Astera Labs, Inc. reported Net Income of $219.13 million for fiscal year 2025.
  • Astera Labs, Inc. showed an increase of +362.7% in Net Income compared to the prior fiscal year.
  • Astera Labs, Inc. reported Diluted EPS of $1.22 per share for fiscal year 2025.
  • Astera Labs, Inc. showed an increase of +290.6% in Diluted EPS compared to the prior fiscal year.
  • Astera Labs, Inc. reported Total Assets of $1.53 billion for fiscal year 2025.
  • Astera Labs, Inc. showed an increase of +45.3% in Total Assets compared to the prior fiscal year.
  • Astera Labs, Inc. reported Cash and Equivalents of $167.61 million for fiscal year 2025.
  • Astera Labs, Inc. showed an increase of +110.7% in Cash and Equivalents compared to the prior fiscal year.
  • Astera Labs, Inc. reported Stockholders Equity of $1.36 billion for fiscal year 2025.
  • Astera Labs, Inc. showed an increase of +41.3% in Stockholders Equity compared to the prior fiscal year.
  • Astera Labs, Inc. reported R&D Expense of $304.00 million for fiscal year 2025.
  • Astera Labs, Inc. showed an increase of +51.4% in R&D Expense compared to the prior fiscal year.
  • Astera Labs, Inc. reported Operating Income of $173.42 million for fiscal year 2025.
  • Astera Labs, Inc. showed an increase of +249.4% in Operating Income compared to the prior fiscal year.
  • Astera Labs, Inc. reported Gross Profit of $645.26 million for fiscal year 2025.
  • Astera Labs, Inc. showed an increase of +113.2% in Gross Profit compared to the prior fiscal year.
  • Astera Labs, Inc. reported Shares Outstanding of 170.19 million shares for fiscal year 2025.
  • Astera Labs, Inc. showed an increase of +5.0% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment